Revance Therapeutics

YTD

ALL

Why Robinhood?

You can watch RVNC and buy or sell other stocks, ETFs, and their options commission-free!

About RVNC

Revance Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications. The firm focuses on production of daxibotulinumtoxinA, a botulinum toxin, for aesthetic and therapeutic indications including facial wrinkles and muscle movement disorders.

CEO

Jeffery A. Bedard

CEOJeffery A. Bedard

Employees

—

Employees—

Headquarters

Nashville, Tennessee

HeadquartersNashville, Tennessee

Founded

1999

Founded1999

Employees

—

Employees—

RVNC Key Statistics

Market cap

382.87M

Market cap382.87M

Price-Earnings ratio

-1.90

Price-Earnings ratio-1.90

Dividend yield

—

Dividend yield—

Average volume

697.72K

Average volume697.72K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$7.56

52 Week high$7.56

52 Week low

$2.30

52 Week low$2.30

People also own

Based on the portfolios of people who own RVNC. This list is generated using Robinhood data, and it’s not a recommendation.